Why $MBOT is about to explode.. A whole new class of medical robots at an absolute steal!

Hey guys..
\*updating this because it didn't even scratch the surface of how massive this tech actually is!\*

MBOT’s LIBERTY system targets complex vascular procedures that are a massive pain for both doctors and patients. This isn't just a lab concept—it was tested by the absolute best research-doctors in top-tier world-class hospitals (including Memorial Sloan Kettering). 
Look at these perfect metrics from the official ACCESS-PVI report.. absolutely flawless:
• 100% successful robotic navigation in all cases.. zero switching to manual manipulation! 
• 0% adverse device effects reported.. a perfect safety profile! 
• 92% relative reduction in radiation exposure for the operator! 
• Maximum 5/5 performance score from investigators on ease of use, tool stability, and overall satisfaction! 

But here is the real kicker that Wall Street doesn't know how to price yet: LIBERTY is the first miniaturized, portable, single-use endovascular robotic system on the market. It completely eliminates the millions in upfront costs and massive physical footprint required by old capital equipment.
Because it's a disposable, single-use device, it's a pure razor-and-blade recurring revenue model!
Every single procedure means a new sale!
Right now it’s approved for vascular/blood-clot adjacent procedures, but they are already successfully testing it for massive routine monitoring applications like Prostate cancer screenings.
The TAM expansion here is just ridiculous.

This company is introducing a brand new class of robots.. At \~$1.87 right now, the market is completely mispricing this asset. It's stupid cheap. A rare ground-floor entry point before the entire market wakes up and sends it to the moon..

Don't miss this ride!! 🚀🚀